Thermo Fisher Scientific Influenza A H1N1 NP Synthetic Peptide

Applications

Control (Ctrl)

• Assay-dependent

Blocking Assay (BLOCK)

• Assay-dependent

Product Specifications

Product Specific Information

This peptide is recommended for use as a positive control in ELISA applications.

Target Information

Influenza viruses consist of three types (Influenza A, B, and C), which make up three of the five genera in the Orthomyxoviridae family. Commonly known as the flu, influenza strains can affect both birds and mammals. Influenza strains form roughly spherical particles and are similar in composition with viral envelope containing two main types of glycoproteins (hemagglutinin and neuraminidase), wrapped around the central core of the viral RNA genome and other viral proteins that package and protect the RNA. Unusually for a virus, the influenzavirus genome is not a single piece of nucleic acid; rather it consists of seven to eight segmented fragments of negative-sense RNA, each expressing different viral proteins. Influenza spreads seasonally, resulting in about three to five million yearly cases of severe illness and about 250,000 to 500,000 deaths annually, or into the millions in pandemic years.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.